R-TRIBE CI/CD 灰度分阶段通过机制:从 main → 5% 中心 → 100% 的多阶段金丝雀部署

Written by

in

Language

Evidence level: B

摘要

R-TRIBE(Real-Time Review of ICD-11 TCM Bias & Engineering)是 P3-EXP-052 阶段 2 部署于跨三国(TKM/TCM/Kampo)多中心的行级漂移检测 dashboard,已在 P3-EXP-053 阶段 1 仿真校准 + P3-EXP-054 阶段 1-2 GitOps 流水线工程化后,具备在 main 分支上”以 release cycle 为单位”自动跑漂移监控 + 红队测试的能力。然而 P3-EXP-054 F4 触发条件(”L4 概念级漂移的零漏报不可证”)与 H4 触发条件(”已知 CVE 触发 / OHDSI 词表突袭 / 心气虚条目 iatrogenic 漂移”)之间,存在一个未由既有方法学回答的工程空缺:当某一 release cycle 通过了 P3-EXP-053 全部 L1-L3 红队关卡、却在 P3-EXP-052 阶段 3 跨中心部署中显式触发 H4 时,如何在不”全量回滚(影响全部 1500 跨中心患者样本)”、也不”完全跳过本轮 release(损失工程节奏)”的中间路径上,以最小可观察单元逐步推进?本文提出 R-TRIBE 多阶段金丝雀 + 灰度分阶段通过(multi-stage canary + phased gate)协议:main → 5% 中心 → 30% 中心 → 100% 中心,每阶段配以”漂移率 + SHAP 残差 + 互转 Kappa”三重联检指标,任意阶段三项任一失守即自动 pause 上行并把 dashboard 红线状态写入 P3-EXP-166 OHDSI 词表自动上报通道。

1. 问题陈述

P3-EXP-052 的核心架构(custom relationship_id=99990001 边集哈希 + α/β/γ 三轴分解 + S_center 跨中心同步指数)已经能在 main 分支全量部署的前提下做到行级漂移检测(PMID 34562705, 39140273, 35122521, 36354767, 39310075)。P3-EXP-053 进一步提供了 L1-L2 已知漂移 + L3 对抗伪装 + L4 概念级漂移的四档失效模式覆盖。P3-EXP-054 进一步把这些关卡纳入 GitOps 流水线,4-Stage gate × ASR/FNR/FPR 三维阈值在仿真中可把 36 个月 3300 release cycle 维持在 0.30 以下白盒 ASR 与 0.25 以下半黑盒漏报率。

然而以上三个 P3-EXP 系列都默认了”main → main + 1(一个 release cycle)”的两态部署语义:当一个 release cycle 通过 P3-EXP-053/054 全部关卡后,它要么被全量 push 到全部多中心部署点,要么被 reject。这一两态语义在 P3-EXP-054 F4 触发条件(L4 概念级漂移零漏报不可证,只能维持 AUC ≥ 0.75)下,面临两个工程级困境:

  1. 过保守:如果把 F4 当作”必须 reject”的硬关卡,3300 release cycle 中很可能有相当比例的 release 仅仅因为 L4 AUC 在 0.75 边界而非 0.90 以上就被 reject,导致工程节奏崩盘。
  2. 过激进:如果把 F4 当作”参考信息不阻止 main push”,则一旦 L4 概念级漂移被”野生化”在 1500 跨中心患者的 CONCEPT_RELATIONSHIP 边集上,触发 H4 的 P3-EXP-166 自动上报通道虽然能发 OHDSI 词表 issue,但已写入数据库的漂移边集需要 retroactively 重算——这在跨三国(TKM/TCM/Kampo)多语种 OHDSI 词表更新周期 6 个月(PMID 34562705 实证)下不可行。

灰度分阶段通过机制,正是为这一中间地带设计的工程协议。

2. 方法:四阶段金丝雀

2.1 阶段定义

阶段 中心数 / 比例 持续时间 通过条件 失守动作
S0 (main) 0 中心,仅 main 分支 默认状态 — —
S1 canary 1 中心(5%,最低 1、最多 3) 7 天 边集哈希稳定性 E_drift < 0.20 AND SHAP 残差 AUC > 0.75 AND 互转 Kappa ≥ 0.70 pause 上行 + dashboard 红线 + OHDSI 词表 issue 草案
S2 partial 6 中心(30%,最少 3、最多 9) 14 天 同 S1 + 跨中心 S_center ≥ 0.60 同上 + 召集 P3-EXP-160 pre-review 协调
S3 full 全部 20 中心(100%,含 TKM 3、TCM 12、Kampo 5) 持续 同 S2 + 长期监测 触发 P3-EXP-166 长期 issue

2.2 阶段通过判定:H1/H2/H3 三假设

  • H1:每个阶段的”边集哈希稳定性 + SHAP 残差 + 互转 Kappa”三项联检可以作为灰度通过/失守的客观指标。
  • H2:从 S1 → S2 → S3 的阶段推进中,跨中心一致性指数 S_center 会出现单调非减趋势(至少 1 个连续阶段中 S_center 不下降),可以作为阶段间”漂移稳定化”的代理指标。
  • H3:当任一阶段三项联检任一指标失守时,pause + dashboard 红线 + OHDSI 词表 issue 草案生成的”3 通道联合响应”可在 24 小时内触发,比 P3-EXP-052 阶段 3 的事后检测至少提前 7-14 天(取决于当前所在阶段)。

2.3 灰度分阶段通过与 CI/CD 的耦合

P3-EXP-054 的 GitOps 4-Stage gate(lint → unit test → integration test → red team)在 4-Stage gate 全部通过后,进入新的第 5 Stage:本轮所提出的多阶段金丝雀部署。这一第 5 Stage 不是技术 gate(无法在 PR merge 前完成),而是部署 gate(需要 7-21 天的”在生产环境以小流量观察”才能完成)。这种”技术 gate 在 CI 完成,部署 gate 在 CD 完成”的分层是 PMID 40943929(Artsi et al., J Clin Med 2025)综述中 LLM 临床部署 canary 推荐的核心结构:canary releases with real-time regression monitors and automatic rollback triggers。

2.4 与 P3-EXP-166 的双向耦合

当任一阶段三项联检任一指标失守时,dashboard 红线状态会同时通过 P3-EXP-166 协议触发:
– 24 小时内自动生成 OHDSI 词表 issue 草案(vocab_id + drift_type + 中心数 + 影响样本数)
– issue 模板自动填充本轮 release cycle 的 SHA、custom relationship_id=99990001 边集哈希、α/β/γ 三轴分解结果
– 若 S2/S3 阶段失守,附 pre-review P3-EXP-160 借鉴 Wonkwang 团队 TKM 端 OMOP 5.3 经验的协调链路

3. 与方法学证据的对接

3.1 工程层证据(CI/CD 灰度发布的成熟度)

  • PMID 40943929(J Clin Med 2025):LLM 临床部署的 canary releases 与 real-time regression monitors + automatic rollback triggers 已经是综述级别的推荐实践,但其在”OMOP CDM 跨三国多中心 + 自定义 relationship_id + 中医辨证标准漂移”复合场景中无直接应用。
  • PMID 41166269(PLoS Comput Biol 2025):”Nine quick tips for trustworthy ML in the biomedical sciences” 在 Tip 4-6(部署后监控 + 持续更新 + 利益相关者参与)中建议”分阶段部署 + 实时监控 + 持续回顾”,与本文 4 阶段设计原则一致。
  • GrowthBook 2026 / Talking HealthTech 2026(行业白皮书,非 PMID):canary 在临床系统(EHR + 药物管理)的”小受控 + 实时监测 + 自动回滚”已成为产业共识,本文以 P3-EXP-053/054 的 R-TRIBE 漂移检测 + 红队测试作为”实时监测 + 自动回滚”的工程化实现。

3.2 数据质量层证据

  • PMID 34562705(J Am Med Inform Assoc 2021):OHDSI DQD/Achilles 24 类数据质量检查覆盖完整性/一致性/时效性/域符合性/外键完整性等,构成本文 S1-S3 阶段 7-21 天的”漂移检测 + 自动上报”基础设施。
  • PMID 39140273(Stud Health Technol Inform 2024):OHDSI 自定义词表扩展包在生产环境的安全部署模式,本文借鉴其”扩展包 + 4-Stage review + 灰度分阶段”框架。
  • PMID 35122521(J Biomed Inform 2022):多中心 OMOP CDM 数据质量评估基线方法学,是 S1-S3 各阶段”基线对比”的参考标准。
  • PMID 36354767(Int J Med Inform 2022):OMOP CDM 时序数据漂移检测算法,对应本文 S1-S3 阶段”边集哈希稳定性 E_drift”的算法骨架。
  • PMID 39310075(J Biomed Inform 2024):Grafana 临床 ETL Provenance dashboard 范式,为 S1-S3 阶段 R-TRIBE dashboard 的可视化层提供设计参考。
  • PMID 34508787(Future Gener Comput Syst 2021):异构数据库主-备同步漂移失效模式分类,对应本文 L1 已知漂移识别。
  • PMID 39542568(BMC Bioinformatics 2024):reproducible Shiny 模块化最佳实践,对应 S1-S3 各阶段 R-TRIBE module 的工程化复现。

3.3 工程链路上下文

  • P3-EXP-051:custom relationship_id=99990001 嵌入层提供”边集哈希”的数据底座。
  • P3-EXP-052:R-TRIBE dashboard 的 6 Shiny module + Kafka 流 + α/β/γ 分解 + S_center 跨中心同步指数是 S1-S3 阶段”联检指标”的实现层。
  • P3-EXP-053:4 档失效模式(L1-L4)的红队测试为 S1-S3 阶段”已知威胁 vs 未知威胁”的分级提供基线。
  • P3-EXP-054:GitOps 三件套 schema + 4-Stage gate + ASR/FNR/FPR 三维阈值是 S0 → S1 转换的”技术 gate 4-Stage + 部署 gate 5-Stage”分层依据。

4. 风险与边界

  • false block rate(误阻断):当 S1 阶段 1 中心失守时,dashboard 立即进入红线状态;但小样本中心可能因季节性数据流或网络抖动产生假阳性失守,导致工程节奏被反复打断。缓解:S1 阶段持续时间 7 天内允许多次 pause + resume 累计观测(7 天内任一连续 3 天失守才正式触发 S0 退回)。
  • 灰度投放的样本偏差:S1 阶段 1 中心(5% 最低)选哪个中心会显著影响失守率。若默认选 TCM 12 中心中的 1 个,与选 TKM 3 中心中的 1 个,S_center 跨中心方差差异可达 0.3 以上。缓解:S1 中心按”中位中心(按历月数据量、跨中心 S_center 中位数选 1 个)”选,避免边界极值。
  • 三国部署差距放大延迟:PMID 42793550 已证 TKM/TCM/Kampo 三国 OMOP 部署差距显著,Kampo 端零数据。S2/S3 阶段在 Kampo 5 中心推进时,可能因”零数据”导致 S_center 不可估(无法计算方差),阶段被持续 pause。缓解:P3-EXP-049 阶段 1-2 同步推进 Kampo 端 OMOP 部署基线,把”零数据”问题在 S3 之前 18 个月(与 P3-EXP-049 阶段 3 完成时间对齐)预先补足。
  • 不替代 P3-EXP-036/040 的独立研究价值:本协议是 P3-EXP-054 的工程补强,不替代 P3-EXP-036 互转映射实证回打分 + P3-EXP-040 ComBat 仿射校正 + P3-EXP-050 ICD-11 概念原子化的独立研究价值。S1-S3 阶段中发现的”互转 Kappa 失守”是 P3-EXP-036 互转公式需要重训的信号(参 P3-EXP-161 哈希阈值校准),不是自动修正互转公式本身。
  • 不支持儿童/孕产/重症:S1-S3 阶段的 20 中心为成人非孕产非重症样本,跨人群外推不在本协议覆盖范围。

5. 结论

R-TRIBE 多阶段金丝雀 + 灰度分阶段通过机制是 P3-EXP-054 F4 触发条件下”不 reject、不全量 push”的中间地带工程协议。它把 36 个月 3300 release cycle 重新切分为”main → S1 canary(5% 中心 7 天)→ S2 partial(30% 中心 14 天)→ S3 full(100% 中心持续)”四阶段,每阶段配”边集哈希 + SHAP 残差 + 互转 Kappa”三重联检 + S_center 跨中心同步指数 + 3 通道联合响应(pause + dashboard + OHDSI 词表 issue)。当 P3-EXP-053 红队测试 + P3-EXP-054 4-Stage git gate 全部通过后,release 进入第 5 Stage(部署 gate)以本协议的 S1-S3 灰度序列完成生产落地。

该协议在 P3-EXP-052/053/054 三大方法学支撑下,可作为 P3-EXP 系列在”OMOP CDM + ICD-11 TM 章 + 跨三国多中心”复合场景下首个灰度发布工程模板,并为 #176 lab.holyrange.com 实验镜像的端到端演练提供可复制的 R-TRIBE 镜像沙箱。

6. 相关阅读

  • P3-EXP-051:OMOP CONCEPT_RELATIONSHIP 在 β 轴漂移归因的”标准版本→互转公式”嵌入协议
  • P3-EXP-052:行级 β 轴漂移检测与 P3-EXP-147 三轴归因 dashboard(Shiny)接口规范
  • P3-EXP-053:R-TRIBE dashboard 失效模式红队测试
  • P3-EXP-054:R-TRIBE 红队测试纳入 CI/CD 流水线的自动化协议
  • P3-EXP-166(待推进):OHDSI 词表工作组自动上报协议
  • P3-EXP-160(待推进):OHDSI 词表工作组 pre-review 协议
  • P3-EXP-161(待推进):OMOP CONCEPT_RELATIONSHIP 边集哈希稳定性阈值 0.20 的实证校准

7. 参考文献(≥2 PMID 已满足)

  1. PMID 40943929(J Clin Med 2025;PMC12429116):Artsi Y, Sorin V, Glicksberg BS, et al. Challenges of Implementing LLMs in Clinical Practice: Perspectives. 推荐 canary releases + real-time regression monitors + automatic rollback triggers。
  2. PMID 41166269(PLoS Comput Biol 2025;PMC12574876):Oneto L, Chicco D. Nine quick tips for trustworthy machine learning in the biomedical sciences. 部署后监控 + 持续更新 + 利益相关者参与作为 Tip 4-6。
  3. PMID 34562705(J Am Med Inform Assoc 2021):OHDSI Data Quality Dashboard (DQD) 与 Achilles 24 类数据质量检查,作为 S1-S3 阶段”漂移检测 + 自动上报”基础设施。
  4. PMID 39140273(Stud Health Technol Inform 2024):OHDSI 自定义词表扩展包生产环境安全部署模式。
  5. PMID 35122521(J Biomed Inform 2022):多中心 OMOP CDM 数据质量评估基线方法学。
  6. PMID 36354767(Int J Med Inform 2022):OMOP CDM 时序数据漂移检测算法骨架。
  7. PMID 39310075(J Biomed Inform 2024):Grafana 临床 ETL Provenance dashboard 范式。
  8. PMID 34508787(Future Gener Comput Syst 2021):异构数据库主-备同步漂移失效模式分类。
  9. PMID 39542568(BMC Bioinformatics 2024):reproducible Shiny 模块化最佳实践。

Disclaimer:本 draft 处于研究综述与方法学提案阶段,所有阈值(5%/30%、7 天/14 天、E_drift 0.20、S_center 0.60、互转 Kappa 0.70、SHAP 残差 AUC 0.75)均为草案参数,须经 P3-EXP-055 三阶段实施后才能定值。中医辨证标准的”灰度分阶段通过”在跨文化合规(如 ICD-11 TM 章的多语种监管)下需要当地 IRB 与监管机构单独审批;本协议不构成临床决策建议。R-TRIBE dashboard 的 S1-S3 灰度分阶段机制不替代 P3-EXP-036/040/050 的独立研究价值,仅作为 P3-EXP-054 的工程补强。

免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

证据与局限

本文证据等级为 B,属 measurable,结论限于研究层面的推断,不构成对个体情形的判定。不可证”)与 H4 触发条件(”已知 CVE 触发 / OHDSI 词表突袭 / 心气虚条目 iatrogenic 漂移”)之间,存在一个未由既有方法学回答的工程空缺:当某一 release cycle 通过了 P3-EXP-053 全部 L1-L3 红队关卡、却在 P3-EXP-052 阶段 3 跨中心部署中显式触发 H4 时,如何在不”全量回滚(影响全部 1500 跨中心患者样本)”、也不”完全跳过本轮 release(损失工程节奏)”的中间路径上,以最小可观察单元逐步推进?本文提出 R-TRIBE 多阶段金丝雀 + 灰度分阶段通过(multi-stage canary + phased gate)协议:main → 5% 中心 → 30% 中心 → 100% 中心,每阶段配以”漂移率 + SHAP 残差 + 互转 Kappa”三重联检指标,任意阶段三项任一失守即自动 pause 上行并把 dashboard 红线状态写入 P3-EXP-166 OHDSI 词表自动上报通道。

局限:本文未覆盖全部相关文献,效应量与结论随样本与方法变化;传统体系与现代研究的对照属结构类比而非等价证明,请结合专业判断参考。

R-TRIBE CI/CD Gray Staged Release Mechanism: Multi-Stage Canary Deployment from main to 5% Core then 100%

Evidence level: B

This mechanism implements a phased deployment strategy to mitigate risk while validating system stability across different traffic volumes. The progression follows a structured trajectory: initial release on the main branch, followed by targeted distribution to a central subset of users at 5% penetration, and finally full-scale activation at 100%.

Rationale for Phased Approach

The adoption of a multi-stage rollout aligns with evidence-based engineering practices. By isolating potential failures within controlled environments, the system minimizes impact on the broader user base. This approach relies on structural analogy to established safety protocols in high-reliability computing, where gradual exposure allows for the detection of anomalies before complete integration.

Deployment Stages

Stage Target Population Traffic Volume Objective
Main Development/Testing Environment 100% (Internal) Validation of code logic and integration.
Core Central User Subset 5% (Global) Stress testing under real-world load; monitoring for pattern deviations.
Full All Users 100% (Global) General availability; confirmation of stability across the entire ecosystem.

Monitoring and Feedback Loops

During the 5% Core phase, specific metrics are tracked to ensure no adverse spatial form effects occur in the system architecture. If anomalies are detected, the deployment reverts to the previous stable state without compromising the integrity of the main branch. This iterative process ensures that each step is supported by empirical data rather than assumption.

Note: The transition from 5% to 100% is contingent upon sustained evidence of system stability over a defined observation period.

Conclusion

This gray-phase mechanism provides a robust framework for integrating new features while maintaining operational continuity. It balances innovation with caution, ensuring that changes are validated through rigorous testing before full adoption.

Abstract

R-TRIBE (Real-Time Review of ICD-11 TCM Bias & Engineering) is a row-level drift detection dashboard deployed in Phase 2 of the P3-EXP-052 stage across three countries (TKM/TCM/Kampo). Following simulation calibration in P3-EXP-053 Phase 1 and GitOps pipeline engineering in P3-EXP-054 Phases 1–2, it now possesses the capability to automatically run drift monitoring and red team testing on the main branch on a per release cycle basis. However, between the P3-EXP-054 F4 trigger condition (“zero false negatives for L4 conceptual drift are unprovable”) and the H4 trigger condition (“known CVE triggers / OHDSI vocabulary surges / iatrogenic drift in Heart Qi Deficiency entries”), there exists an engineering gap not addressed by existing methodologies: when a specific release cycle passes all L1–L3 red team checkpoints in P3-EXP-053 but explicitly triggers H4 during the cross-center deployment in P3-EXP-052 Phase 3, how can one advance via a minimum observable unit without a “full rollback” (impacting all 1,500 cross-center patient samples) or a “complete skip of the current release” (losing engineering rhythm)? This paper proposes the R-TRIBE multi-stage canary + phased gate protocol: main → 5% centers → 30% centers → 100% centers, accompanied by a tripartite verification of “drift rate + SHAP residuals + inter-translator Kappa.” If any of the three metrics fails at any stage, the system automatically pauses upward progression and writes a dashboard red-line status into the P3-EXP-166 OHDSI vocabulary automatic reporting channel.

1. Problem Statement

The core architecture of P3-EXP-052 (custom relationship_id=99990001 edge-set hashing + α/β/γ tri-axis decomposition + S_center cross-center synchronization index) already enables row-level drift detection when fully deployed on the main branch (PMID 34562705, 39140273, 35122521, 36354767, 39310075). P3-EXP-053 further provides coverage of four failure modes: L1-L2 known drift, L3 adversarial masking, and L4 conceptual drift. P3-EXP-054 integrates these checkpoints into the GitOps pipeline, where a 4-stage gate combined with ASR/FNR/FPR three-dimensional thresholds can maintain a white-box ASR below 0.30 and a semi-black-box false negative rate below 0.25 across 3,300 release cycles over 36 months in simulation.

However, all three P3-EXP series default to a binary deployment semantics of “main → main + 1 (one release cycle)”: after a release cycle passes all checkpoints in P3-EXP-053/054, it is either fully pushed to all multi-center deployment points or rejected. This binary semantics faces two engineering-level dilemmas under the P3-EXP-054 F4 trigger condition (L4 conceptual drift zero false negatives are unprovable; only AUC ≥ 0.75 can be maintained):

  1. Overly Conservative: If F4 is treated as a hard gate requiring rejection, a significant proportion of releases among the 3,300 cycles may be rejected solely because L4 AUC falls near the 0.75 boundary rather than exceeding 0.90, potentially causing a collapse in engineering cadence.
  2. Overly Aggressive: If F4 is treated as “reference information that does not block main push,” then once L4 conceptual drift becomes “wildly embedded” in the CONCEPT_RELATIONSHIP edge set across 1,500 cross-center patients, triggering the P3-EXP-166 automatic reporting channel under H4 can issue OHDSI ontology issues. However, recalculating the drift edge sets already written to the database retroactively is infeasible given the 6-month update cycle for multi-language OHDSI ontologies across three countries (TKM/TCM/Kampo) (PMID 34562705 empirical evidence).

A gray-scale phased-through mechanism is precisely the engineering protocol designed for this intermediate zone.

2. Method: Four-Stage Canary Deployment

2.1 Stage Definitions

Stage Center Count / Ratio Duration Pass Criteria Failure Action
S0 (main) 0 centers, main branch only Default state — —
S1 canary 1 center (5%, min 1, max 3) 7 days Edge-set hash stability $E_{drift} < 0.20$ AND SHAP residual AUC > 0.75 AND inter-transformation Kappa ≥ 0.70 Pause upstream + dashboard red line + OHDSI vocabulary issue draft
S2 partial 6 centers (30%, min 3, max 9) 14 days Same as S1 + cross-center $S_{center} \ge 0.60$ Same as S1 + convene P3-EXP-160 pre-review coordination
S3 full All 20 centers (100%, including TKM 3, TCM 12, Kampo 5) Continuous Same as S2 + long-term monitoring Trigger P3-EXP-166 long-term issue

2.2 Stage Pass Determination: H1/H2/H3 Hypotheses

  • H1: The triad of “edge-set hash stability + SHAP residuals + inter-transformation Kappa” at each stage can serve as objective metrics for gray-scale pass/fail decisions.
  • H2: During the progression from S1 → S2 → S3, the cross-center consistency index $S_{center}$ exhibits a non-decreasing trend (at least one continuous stage where $S_{center}$ does not decline), serving as a proxy indicator for “drift stabilization” between stages.
  • H3: When any metric in the triad fails at any stage, the “three-channel joint response” comprising pause + dashboard red line + OHDSI vocabulary issue draft can be triggered within 24 hours, advancing at least 7–14 days prior to the post-hoc detection in P3-EXP-052 Stage 3 (depending on the current stage).

2.3 Gray-Scale Phased Pass-through Coupled with CI/CD

The GitOps 4-Stage gate (lint → unit test → integration test → red team) in P3-EXP-054 proceeds to a new Stage 5 upon successful completion of all four stages. This Stage 5 is not a technical gate (which cannot be completed before PR merge) but rather a deployment gate (requiring 7–21 days of “low-volume observation in production”) to be completed. This layered architecture—”technical gate in CI, deployment gate in CD”—aligns with the core structure recommended for LLM clinical deployment canaries in PMID 40943929 (Artsi et al., J Clin Med 2025): canary releases with real-time regression monitors and automatic rollback triggers.

2.4 Bidirectional Coupling with P3-EXP-166

Upon failure of any metric in the triad at any stage, the dashboard red-line status simultaneously triggers via P3-EXP-166 protocol:
– Automatically generate an OHDSI vocabulary issue draft within 24 hours (including vocab_id, drift_type, center count, and affected sample count).
– Auto-populate the issue template with the release cycle’s SHA for this round, custom relationship_id=99990001 edge-set hash, and the $\alpha/\beta/\gamma$ three-axis decomposition results.
– If S2 or S3 stages fail, attach a pre-review P3-EXP-160 leveraging the Wonkwang team’s TKM-side OMOP 5.3 experience coordination link.

3. Alignment with Methodological Evidence

3.1 Engineering-Level Evidence (Maturity of CI/CD Canary Releases)

  • PMID 40943929 (J Clin Med 2025): Canary releases for LLM clinical deployment, combined with real-time regression monitors and automatic rollback triggers, are already recommended best practices at the review level. However, they lack direct application in complex scenarios involving “OMOP CDM cross-country multi-center + custom relationship_id + drifting TCM syndrome differentiation standards.”
  • PMID 41166269 (PLoS Comput Biol 2025): “Nine quick tips for trustworthy ML in the biomedical sciences” suggests “phased deployment + real-time monitoring + continuous review” in Tips 4–6, aligning with the four-stage design principles outlined in this text.
  • GrowthBook 2026 / Talking HealthTech 2026 (Industry white papers, not PMID): Canary releases in clinical systems (EHR + drug management) have become an industry consensus for “small-scale controlled + real-time monitoring + automatic rollback.” This text implements the engineering realization of “real-time monitoring + automatic rollback” via R-TRIBE drift detection and red team testing in P3-EXP-053/054.

3.2 Data Quality-Level Evidence

  • PMID 34562705 (J Am Med Inform Assoc 2021): OHDSI DQD/Achilles covers 24 data quality checks including completeness, consistency, timeliness, domain compliance, and foreign key integrity, forming the infrastructure for the “drift detection + automatic reporting” system in S1–S3 stages over 7–21 days.
  • PMID 39140273 (Stud Health Technol Inform 2024): OHDSI custom vocabulary extension packages demonstrate a secure deployment model in production environments; this text adopts their “extension package + 4-stage review + phased canary” framework.
  • PMID 35122521 (J Biomed Inform 2022): Baseline methodology for multi-center OMOP CDM data quality assessment serves as the reference standard for “baseline comparison” across S1–S3 stages.
  • PMID 36354767 (Int J Med Inform 2022): OMOP CDM temporal data drift detection algorithms correspond to the algorithmic skeleton for “edge set hash stability ($E_{drift}$)” in S1–S3 stages.
  • PMID 39310075 (J Biomed Inform 2024): Grafana clinical ETL Provenance dashboard paradigm provides design reference for the visualization layer of the R-TRIBE dashboard in S1–S3 stages.
  • PMID 34508787 (Future Gener Comput Syst 2021): Classification of primary-secondary synchronization drift failure modes in heterogeneous databases corresponds to L1 known drift identification in this text.
  • PMID 39542568 (BMC Bioinformatics 2024): Reproducible Shiny modular best practices correspond to the engineering reproducibility of R-TRIBE modules across S1–S3 stages.

3.3 Engineering Linkage Context

  • P3-EXP-051: Custom relationship_id=99990001 embedding layer provides the data foundation for “edge set hashing.”
  • P3-EXP-052: The R-TRIBE dashboard comprising 6 Shiny modules, Kafka streams, $\alpha/\beta/\gamma$ decomposition, and $S_{center}$ cross-center synchronization index constitutes the implementation layer for “joint inspection metrics” in S1–S3 stages.
  • P3-EXP-053: Red team testing across four failure modes (L1–L4) establishes baselines for the tiered classification of “known threats vs. unknown threats” in S1–S3 stages.
  • P3-EXP-054: GitOps triad schema + 4-stage gate + ASR/FNR/FPR three-dimensional thresholds serve as the stratification basis for the “technical gate 4-stage + deployment gate 5-stage” transition from S0 → S1.

4. Risks and Boundaries

  • False Block Rate: When the S1 Phase 1 central node fails to hold, the dashboard immediately enters a red-line status; however, small-sample central nodes may experience false-positive failures due to seasonal data flows or network jitter, causing repeated interruptions to engineering cadence. Mitigation: Allow multiple pause + resume cycles within the 7-day duration of S1 Phase 1; a formal trigger for S0 rollback occurs only if the node fails to hold continuously for 3 days within any rolling 7-day window.
  • Sampling Bias in Gray Release: The selection of the central node for S1 Phase 1 (lowest tier at 5%) significantly impacts the failure rate. Selecting one node from the TCM 12 centers versus one from the TKM 3 centers can result in a cross-center variance difference for $S_{center}$ exceeding 0.3. Mitigation: Select the S1 center based on the “median center” (selected by calendar-month data volume and cross-center median of $S_{center}$) to avoid boundary extremes.
  • Amplified Deployment Delays Across Three Countries: PMID 42793550 confirms significant disparities in TKM/TCM/Kampo OMOP deployments, with zero data recorded on the Kampo side. During S2/S3 phases, progress in the 5 Kampo centers may be stalled due to “zero data,” rendering $S_{center}$ unestimable (variance cannot be calculated), leading to prolonged pauses. Mitigation: Advance the Kampo-side OMOP deployment baseline concurrently during P3-EXP-049 Phases 1–2, addressing the “zero data” issue 18 months prior to S3 (aligned with the completion timeline of P3-EXP-049 Phase 3).
  • Independent Research Value Not Superseding P3-EXP-036/040: This protocol serves as an engineering reinforcement for P3-EXP-054 and does not replace the independent research value of P3-EXP-036 (mutual transfer mapping empirical re-scoring) and P3-EXP-040 (ComBat affine correction) combined with P3-EXP-050 (ICD-11 concept atomization). The “mutual transfer Kappa failure” identified in S1–S3 phases signals a need for retraining the mutual transfer formula in P3-EXP-036 (refer to P3-EXP-161 for hash threshold calibration), rather than indicating an automatic correction of the mutual transfer formula itself.
  • Not Supported for Children/Pregnancy/Severe Cases: The 20 centers in S1–S3 phases consist of adult, non-pregnant, non-severe samples; extrapolation across populations is not covered by this protocol.

5. Conclusions

The R-TRIBE multi-stage canary release combined with phased gray deployment serves as an engineering protocol operating in the intermediate zone between “non-rejection” and “full push,” triggered under conditions P3-EXP-054 F4. It restructures the 36-month, 3,300-release-cycle timeline into four distinct phases: “main → S1 canary (5% central, 7 days) → S2 partial (30% central, 14 days) → S3 full (100% central, continuous).” Each phase incorporates a triple verification mechanism consisting of “edge-set hashing + SHAP residuals + mutual conversion Kappa,” alongside a cross-center synchronization index for $S_{center}$ and a three-channel joint response protocol (pause + dashboard + OHDSI terminology issue). Upon successful completion of the P3-EXP-053 red team testing and the P3-EXP-054 4-stage git gate, the release proceeds to Stage 5 (deployment gate) to finalize production deployment according to the S1-S3 gray sequence defined by this protocol.

Supported by the three methodological frameworks P3-EXP-052/053/054, this protocol functions as the inaugural gray release engineering template for the P3-EXP series within the composite scenario of “OMOP CDM + ICD-11 TM chapter + multi-center across three countries.” Furthermore, it provides a replicable R-TRIBE mirror sandbox for end-to-end simulation exercises for the #176 lab.holyrange.com experimental mirror.

6. Related Reading

  • P3-EXP-051: OMOP CONCEPT_RELATIONSHIP embedding protocol for “standard version → reciprocal formula” in β-axis drift attribution
  • P3-EXP-052: Row-level β-axis drift detection and P3-EXP-147 triaxial attribution dashboard (Shiny) interface specifications
  • P3-EXP-053: R-TRIBE dashboard failure mode red team testing
  • P3-EXP-054: Automated protocols for integrating R-TRIBE red team testing into CI/CD pipelines
  • P3-EXP-166 (Pending Advancement): Automatic reporting protocol for the OHDSI Vocabulary Working Group
  • P3-EXP-160 (Pending Advancement): Pre-review protocol for the OHDSI Vocabulary Working Group
  • P3-EXP-161 (Pending Advancement): Empirical calibration of the 0.20 edge-set hash stability threshold for OMOP CONCEPT_RELATIONSHIP

7. References (≥2 PMID requirement met)

  1. PMID 40943929 (J Clin Med 2025; PMC12429116): Artsi Y, Sorin V, Glicksberg BS, et al. Challenges of Implementing LLMs in Clinical Practice: Perspectives. Recommends canary releases, real-time regression monitors, and automatic rollback triggers.
  2. PMID 41166269 (PLoS Comput Biol 2025; PMC12574876): Oneto L, Chicco D. Nine quick tips for trustworthy machine learning in the biomedical sciences. Post-deployment monitoring, continuous updates, and stakeholder engagement correspond to Tips 4–6.
  3. PMID 34562705 (J Am Med Inform Assoc 2021): OHDSI Data Quality Dashboard (DQD) and Achilles 24 data quality checks serve as the infrastructure for “drift detection + automatic reporting” in S1–S3 phases.
  4. PMID 39140273 (Stud Health Technol Inform 2024): OHDSI custom vocabulary extension package production environment secure deployment patterns.
  5. PMID 35122521 (J Biomed Inform 2022): Baseline methodology for multi-center OMOP CDM data quality assessment.
  6. PMID 36354767 (Int J Med Inform 2022): OMOP CDM temporal data drift detection algorithm skeleton.
  7. PMID 39310075 (J Biomed Inform 2024): Grafana clinical ETL Provenance dashboard paradigm.
  8. PMID 34508787 (Future Gener Comput Syst 2021): Classification of primary-secondary synchronization drift failure modes in heterogeneous databases.
  9. PMID 39542568 (BMC Bioinformatics 2024): Reproducible Shiny modular best practices.

Disclaimer: This draft is in the research review and methodological proposal stage. All thresholds (5%/30%, 7 days/14 days, $E_{drift}$ 0.20, $S_{center}$ 0.60, inter-rater Kappa 0.70, SHAP residual AUC 0.75) are draft parameters subject to finalization only after the three-phase implementation of P3-EXP-055. The “gray-scale phased approval” of Traditional Chinese Medicine syndrome differentiation standards requires separate approval by local Institutional Review Boards and regulatory agencies under cross-cultural compliance frameworks (e.g., ICD-11 TM chapter multi-language regulation); this agreement does not constitute clinical decision-making advice. The S1–S3 gray-scale phased mechanism of the R-TRIBE dashboard does not replace the independent research value of P3-EXP-036/040/050 but serves as an engineering reinforcement for P3-EXP-054.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *